Login to Your Account

Pharma: Other News To Note

Tuesday, April 9, 2013
• Merz Pharma Group, of Frankfurt, Germany, said it withdrew its nonbinding proposal to acquire the outstanding common stock of Obagi Medical Products Inc., of Long Beach, Calif., for $22 per share in cash.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription